• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

TVM Capital Life Science Venture Capital

Investing in Life Science Innovation

  • About Us
    • Partners
  • Team
  • Senior Advisors
  • Portfolio
  • Funding Request
  • News
  • Events
  • ESG Policy
  • Contact

News

  • Home
  • About Us
  • Team
  • Senior Advisors
  • Portfolio
  • News
  • Events
  • ESG Policy
  • Contact

News

News · February 1, 2022

CENTOGENE Announces USD 62 Million Aggregate Equity and Debt Financings to Support Growth Plan

centogene

Enables refocusing on core business of delivering valuable, data-driven insights to patients, and pharmaceutical companies globally EUR 15 million private placement from leading growth investors and …

News · February 1, 2022

CENTOGENE Announces Nomination of Kim Stratton as Chief Executive Officer

centogene

Dr. Andrin Oswald resigns as CEO due to prolonged medical leave; Kim Stratton elected as successor CAMBRIDGE, Mass. and ROSTOCK, Germany, and BERLIN, February 1, 2022 (GLOBE NEWSWIRE – Centogene …

News · January 18, 2022

TVM Capital Life Science promotes Dr. Sascha Berger and Dr. Alain Thibault to General Partner

Munich, Germany / Montreal, Canada - 12 January 2022 – TVM Life Science (“TVM”), a leading International Life Sciences Venture Capital firm, today announces the formal promotion of Dr. Sascha Berger …

News · January 13, 2022

Syndivia and TVM Capital Life Science Announce Creation of Auricula Biosciences to Develop Innovative Therapy for Patients with K-Ras mutant malignancies

laboratory

Luxembourg, January 13th, 2022 – TVM Life Science Innovation II SCSp announced the Fund's investment establishing Auricula Biosciences, Inc., a company based in Wilmington, Delaware, USA. Auricula …

News · November 22, 2021

Acer Therapeutics Reports Q3 2021 Financial Results and Provides Corporate Update

laboratory

NEWTON, MA – Nov. 19, 2021 – Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and …

News · November 16, 2021

Kent Imaging – Setting A New Global Standard in Advanced Tissue Assessment

handheld-kent-imaging

November 16, 2021 Kent Imaging is a market leader in light-based tissue assessment diagnostic devices. The company designs and manufactures imaging technology that supports real-time …

  • « Go to Previous Page
  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to page 4
  • Interim pages omitted …
  • Go to page 50
  • Go to Next Page »

Primary Sidebar

Secondary Sidebar

Additional News

Kent Imaging Recognized as Most Innovative Medical Imaging Technology Developer in Canada

June 23, 2022

Egg Medical hatches technology to shield health care workers from radiation

March 29, 2022

Egg Medical hatches $13M VC funding

March 15, 2022

Egg Medical, Inc., Closes on $13 million Financing

March 3, 2022

CENTOGENE Announces CFO Transition and Appointment of Miguel Coego Rios as EVP Finance & Legal and Interim CFO

February 8, 2022

  • in

Copyright © 2022 · TVM Capital Life Science Venture Capital · ESG Disclosure · Privacy Policy · Contact